Homework Help is Here – Start Your Trial Now!
Science
Nursing
2 A researcher is studying the effects of a novel cancer drug on cell division and comparing the new drug to a traditional chemotherapy drug. The traditional drug causes numerous side effects such as nausea, vomiting, hair loss and susceptibility to infections due to low white blood cell counts. The novel drug is a targeted therapy (specifically targets the abnormal protein in the cancer cell) and is likely to reduce side effects that patients experience when treated with traditional chemotherapy. One group of cancer patients was treated with the novel drug and a second group of cancer patients was treated with the traditional chemotherapy drug. Prior and subsequent to treatment, a mitotic index was obtained from a tumor sample from each patient as well as a bone marrow sample (bone marrow cells give rise to all blood cell types including red blood cells and white blood cells). Since this is a double-blind study (neither the patient nor the researcher knows which patients received which drug), the patient samples were labelled with the patients' initials but no information was provided with respect to the drug each patient was receiving. Below is the data for four different patients. Mitotic index was used to measure the effectiveness of each drug treatment. Use the data below to answer the following questions: Patient ID MI bone marrow cells MI bone marrow MI tumor cells MI tumor cells before treatment cells after treatment before treatment after treatment MJ 0.15 0.07 0.44 0.25 JS 0.17 0.15 0.55 0.08 TE 0.14 0.13 0.47 0.05 KR 0.17 0.04 0.51 0.32 b. Which patient(s) do you think were treated with the novel targeted drug therapy? Explain your answer by referencing the data provided in the table.

2 A researcher is studying the effects of a novel cancer drug on cell division and comparing the new drug to a traditional chemotherapy drug. The traditional drug causes numerous side effects such as nausea, vomiting, hair loss and susceptibility to infections due to low white blood cell counts. The novel drug is a targeted therapy (specifically targets the abnormal protein in the cancer cell) and is likely to reduce side effects that patients experience when treated with traditional chemotherapy. One group of cancer patients was treated with the novel drug and a second group of cancer patients was treated with the traditional chemotherapy drug. Prior and subsequent to treatment, a mitotic index was obtained from a tumor sample from each patient as well as a bone marrow sample (bone marrow cells give rise to all blood cell types including red blood cells and white blood cells). Since this is a double-blind study (neither the patient nor the researcher knows which patients received which drug), the patient samples were labelled with the patients' initials but no information was provided with respect to the drug each patient was receiving. Below is the data for four different patients. Mitotic index was used to measure the effectiveness of each drug treatment. Use the data below to answer the following questions: Patient ID MI bone marrow cells MI bone marrow MI tumor cells MI tumor cells before treatment cells after treatment before treatment after treatment MJ 0.15 0.07 0.44 0.25 JS 0.17 0.15 0.55 0.08 TE 0.14 0.13 0.47 0.05 KR 0.17 0.04 0.51 0.32 b. Which patient(s) do you think were treated with the novel targeted drug therapy? Explain your answer by referencing the data provided in the table.

Phlebotomy Essentials
Phlebotomy Essentials
6th Edition
ISBN:9781451194524
Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Chapter1: Phlebotomy: Past And Present And The Healthcare Setting
Section: Chapter Questions
Problem 1SRQ
See similar textbooks
icon
Related questions
icon
Concept explainers
Question
2. A researcher is studying the effects of a novel cancer drug on cell division and comparing the new drug to a traditional chemotherapy drug. The traditional drug causes numerous side effects such as nausea, vomiting, hair loss and susceptibility to infections due to low white blood cell counts. The novel drug is a targeted therapy (specifically targets the abnormal protein in the cancer cell) and is likely to reduce side effects that patients experience when treated with traditional chemotherapy. One group of cancer patients was treated with the novel drug and a second group of cancer patients was treated with the traditional chemotherapy drug. Prior and subsequent to treatment, a mitotic index was obtained from a tumor sample from each patient as well as a bone marrow sample (bone marrow cells give rise to all blood cell types including red blood cells and white blood cells). Since this is a double-blind study (neither the patient nor the researcher knows which patients received which drug), the patient samples were labelled with the patients' initials but no information was provided with respect to the drug each patient was receiving. Below is the data for four different patients. Mitotic index was used to measure the effectiveness of each drug treatment. Use the data below to answer the following questions: Patient ID MI bone marrow cells MI bone marrow MI tumor cells MI tumor cells before treatment cells after treatment before treatment after treatment MJ 0.15 0.07 0.44 0.25 JS 0.17 0.15 0.55 0.08 TF 0.14 0.13 0.47 0.05 KR 0.17 0.04 0.51 0.32 b. Which patient(s) do you think were treated with the novel targeted drug therapy? Explain your answer by referencing the data provided in the table.
Transcribed Image Text:2. A researcher is studying the effects of a novel cancer drug on cell division and comparing the new drug to a traditional chemotherapy drug. The traditional drug causes numerous side effects such as nausea, vomiting, hair loss and susceptibility to infections due to low white blood cell counts. The novel drug is a targeted therapy (specifically targets the abnormal protein in the cancer cell) and is likely to reduce side effects that patients experience when treated with traditional chemotherapy. One group of cancer patients was treated with the novel drug and a second group of cancer patients was treated with the traditional chemotherapy drug. Prior and subsequent to treatment, a mitotic index was obtained from a tumor sample from each patient as well as a bone marrow sample (bone marrow cells give rise to all blood cell types including red blood cells and white blood cells). Since this is a double-blind study (neither the patient nor the researcher knows which patients received which drug), the patient samples were labelled with the patients' initials but no information was provided with respect to the drug each patient was receiving. Below is the data for four different patients. Mitotic index was used to measure the effectiveness of each drug treatment. Use the data below to answer the following questions: Patient ID MI bone marrow cells MI bone marrow MI tumor cells MI tumor cells before treatment cells after treatment before treatment after treatment MJ 0.15 0.07 0.44 0.25 JS 0.17 0.15 0.55 0.08 TF 0.14 0.13 0.47 0.05 KR 0.17 0.04 0.51 0.32 b. Which patient(s) do you think were treated with the novel targeted drug therapy? Explain your answer by referencing the data provided in the table.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Knowledge Booster
Macromolecules
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, nursing and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Phlebotomy Essentials
Phlebotomy Essentials
Nursing
ISBN:
9781451194524
Author:
Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:
JONES+BARTLETT PUBLISHERS, INC.
Gould's Pathophysiology for the Health Profession…
Gould's Pathophysiology for the Health Profession…
Nursing
ISBN:
9780323414425
Author:
Robert J Hubert BS
Publisher:
Saunders
Fundamentals Of Nursing
Fundamentals Of Nursing
Nursing
ISBN:
9781496362179
Author:
Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.
Publisher:
Wolters Kluwer,
Fundamentals of Nursing, 9e
Fundamentals of Nursing, 9e
Nursing
ISBN:
9780323327404
Author:
Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNE
Publisher:
Elsevier Science
Study Guide for Gould's Pathophysiology for the H…
Study Guide for Gould's Pathophysiology for the H…
Nursing
ISBN:
9780323414142
Author:
Hubert BS, Robert J; VanMeter PhD, Karin C.
Publisher:
Saunders
Issues and Ethics in the Helping Professions (Min…
Issues and Ethics in the Helping Professions (Min…
Nursing
ISBN:
9781337406291
Author:
Gerald Corey, Marianne Schneider Corey, Cindy Corey
Publisher:
Cengage Learning
SEE MORE TEXTBOOKS